ULORIC (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the ULORIC drug offered from Takeda Pharmaceuticals America, Inc.. This Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | febuxostat |
| SUBSTANCE NAME: | FEBUXOSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-02-13 |
| END MARKETING DATE: | 0000-00-00 |
ULORIC HUMAN PRESCRIPTION DRUG Details:
| Item Description | ULORIC from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80(mg/1) |
| START MARKETING DATE: | 2009-02-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-677_2086116f-ebb2-47ee-a741-30a7f71c4451 |
| PRODUCT NDC: | 64764-677 |
| APPLICATION NUMBER: | NDA021856 |
Other FEBUXOSTAT Pharmaceutical Manufacturers / Labelers:
